Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.
about
Validation of functional imaging as a biomarker for radiation treatment responseImaging tumour hypoxia with positron emission tomographyThe clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesPositron emission tomography to assess hypoxia and perfusion in lung cancerMedical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR)Image-guided PO2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats.Analysis of pairwise correlations in multi-parametric PET/MR data for biological tumor characterization and treatment individualization strategies.Molecular mechanisms of hypoxia in cancer.Clinical biomarkers for hypoxia targetingA new peptide ligand for targeting human carbonic anhydrase IX, identified through the phage display technology.PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidenceNoninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regions.Delivery rate affects uptake of a fluorescent glucose analog in murine metastatic breast cancer.Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study.The promise and pitfalls of positron emission tomography and single-photon emission computed tomography molecular imaging-guided radiation therapy.F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapyCorrelation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynxQuantitative and qualitative analysis of [(18)F]FDG and [(18)F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome.Biological characteristics of intratumoral [F-18]‑fluoromisonidazole distribution in a rodent model of glioma.FDG uptake, a surrogate of tumour hypoxia?Electron paramagnetic resonance oxygen image hypoxic fraction plus radiation dose strongly correlates with tumor cure in FSa fibrosarcomasQuantitative multimodality imaging in cancer research and therapyNovel imaging approaches to head and neck cancerTargeting the metabolic microenvironment of tumors.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Molecular imaging of hypoxia with radiolabelled agentsTargeting the hypoxia-inducible factor (HIF) pathway in cancer.Microfluidics for positron emission tomography probe development.Innovation in cancer imaging.Imaging hypoxia to improve radiotherapy outcome.Predicting tumour response.Molecular imaging of tumor hypoxia with positron emission tomography.PET imaging biomarkers in head and neck cancer.The role of necrosis, acute hypoxia and chronic hypoxia in (18)F-FMISO PET image contrast: a computational modelling study.Tumor hypoxia: a new PET imaging biomarker in clinical oncology.Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study.A robotic system for F18-FMISO PET-guided intratumoral pO2 measurements.Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements.Hypoxia as a Biomarker and for Personalized Radiation Oncology.
P2860
Q26823165-8ED4AC9C-227B-411D-9940-B5FB583E06AEQ26851422-0FB8F105-1D2B-433B-B5A2-40C2BA5EC9DDQ27025579-B5E1B8A9-8B90-45AB-8ECE-6295466AA848Q27026940-7D62C8FA-4D8C-43BC-B190-49994E16FA81Q28651176-440E9B90-8DE2-42B0-B82A-541DFD62E272Q30559873-A5E37D26-16A3-498F-B36F-DC682525BD29Q31044830-EF7B38A2-49DF-4556-B7A9-D5399FCF5F8CQ33705108-96DD23A1-6CEF-4C9A-9F04-C56482D3911FQ33714638-C0B6C4CB-507D-4566-A1E5-16FEF50AE35BQ33786760-D0BE0F21-622D-4034-942D-4B8A6E9C9E68Q33818999-ADBB204F-A81D-4415-AC50-54A599605DDDQ33925417-15A3BB18-FE5C-4D53-B72D-B31D6F34C813Q34050564-122638E5-295D-42AC-A996-7D1D7EB9A70CQ35034709-5525B4DB-B499-495C-9B87-BCD06B0882C6Q35078927-496F16D1-6E70-49B5-A0ED-6D1A8F10C5B2Q35111985-D45926D2-A410-441A-B3DF-F81FE7D6EC7BQ35116993-DFFBEA60-B289-4CDC-A6D2-E1C32EEEBA78Q36387970-3F425006-AEE1-4F92-9DCF-CA03F7872A63Q36619504-92EE2961-8F4A-419D-9A0E-E2083CD20B43Q36684412-161D0CA3-DE49-4712-81D1-37BBFF6EF8F1Q36800336-58BF2D19-FC1F-4D67-8869-3840C7247FCBQ36960941-051FB110-C03B-4E6B-B6A3-43103D2174FCQ37007810-C3BDDA76-401A-45AC-90C3-63F1549B02DFQ37012938-2A68B687-AAC0-4FAF-BA91-7E4FB42D9002Q37229190-54278431-39E5-4135-ADD6-BAA8FB7B9D5FQ37236103-4464BAEC-A42A-42BC-AAAA-575F99B6D0B5Q37378239-32A696F2-20EC-4894-A151-54D81EE195EBQ37587446-D710235B-7DA3-45BF-B421-9A05B4708F33Q37774061-647FE348-3433-44C5-AC6C-09BEFC9D2629Q38005915-34CFB1EC-D9F3-42EB-A516-EA6C3179CF4CQ38059626-91AFAF00-97A0-4224-961D-D780A70D098EQ38141699-E1D303D4-5299-42F6-8497-29A8187D4709Q38199721-93A6FE71-C6F1-4BEC-B987-E05D11B100F4Q38312362-5D0F3378-247A-41DE-A396-EC4C06863F40Q38404220-3F53ACBC-3A41-4472-9C0E-048675C3788DQ38411275-75B2823F-C816-45AE-A7FA-3F73C5D4EBC7Q38418282-0F408477-4A30-47D1-B063-951044BB65AAQ38774781-ACA54E16-43EC-4C83-83EA-1A11A76FF60BQ38837272-0A4ADEF9-52FE-4204-9A33-F09E9C48D6C4Q38869433-705843DA-237C-477B-AAAF-F8124BAA7B7F
P2860
Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Combined uptake of [18F]FDG an ...... head-and-neck cancer patients.
@ast
Combined uptake of [18F]FDG an ...... head-and-neck cancer patients.
@en
type
label
Combined uptake of [18F]FDG an ...... head-and-neck cancer patients.
@ast
Combined uptake of [18F]FDG an ...... head-and-neck cancer patients.
@en
prefLabel
Combined uptake of [18F]FDG an ...... head-and-neck cancer patients.
@ast
Combined uptake of [18F]FDG an ...... head-and-neck cancer patients.
@en
P2093
P1476
Combined uptake of [18F]FDG an ...... head-and-neck cancer patients
@en
P2093
Felix Holzner
Frank Paulsen
Markus Alber
Susanne-Martina Eschmann
P304
P356
10.1016/J.RADONC.2006.07.033
P577
2006-08-21T00:00:00Z